Hussman Strategic Advisors, Inc. Jazz Pharmaceuticals PLC Transaction History

Hussman Strategic Advisors, Inc.

$386 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$126.59 - $161.18 $253,180 - $322,360	2,000 Added 19.23%	12,400 $1.65 Million
Q2 2022 Sep 12, 2022	BUY	$141.59 - $168.66 $736,268 - $877,032	5,200 Added 100.0%	10,400 $1.62 Million
Q1 2022 May 04, 2022	SELL	$129.64 - $160.7 $1.35 Million - $1.67 Million	-10,400 Reduced 66.67%	5,200 $809,000
Q4 2021 Jan 31, 2022	SELL	$119.87 - $145.67 $1.1 Million - $1.34 Million	-9,200 Reduced 37.1%	15,600 $1.99 Million
Q3 2021 Nov 01, 2021	BUY	$128.64 - $184.79 $411,647 - $591,328	3,200 Added 14.81%	24,800 $3.23 Million
Q1 2021 May 03, 2021	BUY	$150.19 - $173.5 $165,209 - $190,850	1,100 Added 5.37%	21,600 $3.55 Million
Q4 2020 Feb 01, 2021	BUY	$140.71 - $165.05 $35,177 - $41,262	250 Added 1.23%	20,500 $3.38 Million
Q2 2020 Jul 31, 2020	BUY	$95.68 - $121.88 $478,400 - $609,400	5,000 Added 32.79%	20,250 $2.23 Million
Q1 2020 May 01, 2020	BUY	$87.74 - $152.74 $899,335 - $1.57 Million	10,250 Added 205.0%	15,250 $1.52 Million
Q4 2019 Jan 31, 2020	BUY	$117.65 - $153.73 $588,250 - $768,650	5,000 New	5,000 $746,000
Q2 2019 Jul 31, 2019	SELL	$125.55 - $144.48 $50,220 - $57,791	-400 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$121.81 - $142.95 $2.44 Million - $2.86 Million	-20,000 Reduced 98.04%	400 $57,000
Q4 2018 Feb 01, 2019	BUY	$115.94 - $166.74 $2.37 Million - $3.4 Million	20,400 New	20,400 $2.53 Million
Q1 2018 May 01, 2018	SELL	$135.59 - $157.16 $3.39 Million - $3.93 Million	-25,000 Closed	0 $0
Q4 2017 Jan 31, 2018	BUY	$131.06 - $150.39 $3.28 Million - $3.76 Million	25,000	25,000 $3.37 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.

Account